<PAGE>

               UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                FORM 10-QSB/A

(Mark One)
[X]  Quarterly report under Section 13 or 15(d) of the Securities Exchange
     Act of 1934 for the quarterly period ended September 30, 2001.

[ ]  Transition report under Section 13 or 15(d) of the Securities Exchange
     Act of 1934 (No fee required) for the transition period from
     _______________ to _______________.

Commission file number: 2-90519

                          CENTURY LABORATORIES, INC.
               (Name of small business issuer in its charter)

            Delaware                                         72-0510027
(State or other jurisdiction of                           (I.R.S. Employer
 incorporation or organization)                          Identification No.)

                                730 2nd Street
                          Santa Rosa, CA 95402-3588
              (Address of principal executive offices) (Zip Code)

                   Issuer's telephone number: (707)935-6945)

Check whether the issuer: (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.

                   Yes [X]         No [ ]

The number of shares outstanding of Registrant's common stock ($0.001 par
value) as of the quarter ended September 30, 2001, was 1,110,650, shares with
2527 shareholders of record.



<PAGE>
                              TABLE OF CONTENTS

                                    PART I


                                                                          Page
                                                                          ----

ITEM 1.  FINANCIAL STATEMENTS.............................................3

ITEM 2.  PLAN OF OPERATION................................................3


                                    PART II

ITEM 1.  LEGAL PROCEEDINGS................................................4

ITEM 2.  CHANGES IN SECURITIES............................................4

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES..................................4

ITEM 4.  SUBMISSION TO A VOTE OF SECURITY HOLDERS.........................4

ITEM 5.  OTHER............................................................4

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K.................................4

         SIGNATURES.......................................................5




                                     -2-
<PAGE>

                                    PART I


ITEM 1.  FINANCIAL STATEMENTS

     Unless otherwise indicated, the term "Company" refers to Century
Laboratories, Inc. and its subsidiaries and predecessors.  The accompanying
consolidated unaudited condensed financial statements have been prepared by
management in accordance with the instructions in Form 10-QSB and, therefore,
so not include all information and footnotes required by generally accepted
accounting principles and should, therefore, be read in conjunction with
Company's Annual Report to Shareholders on Form 10-KSB for the fiscal year
ended December 31, 2000.  These statements do include all the normal recurring
adjustments which the Company believes is necessary and affords a fair
presentation.  The interim results are not necessarily indicative of the
results for the full year ending December 31, 2001.  Accordingly, consolidated
audited interim financial statements, including a balance sheet for the
Company as of the fiscal quarter ended September 30, 2001, and, statements of
operations and statements of cash flows for the interim period up to the date
of such balance sheet and the comparable period of the preceding fiscal year
are attached hereto as Pages F-1 through F-4 and are incorporated herein by
this reference.

ITEM 2.  PLAN OF OPERATION

     The following discussion and analysis should be read in conjunction with
the Company's financial statements and notes thereto included elsewhere in
this Form 10- QSB/A.  Except for the historical information contained herein,
the discussion in this Form 10-QSB/A contains certain forward looking
statements that involve risks and uncertainties, such as statements of the
Company's plans, objectives, expectations and intentions.  The cautionary
statements made in this Form 10-QSB/A should be read as being applicable to
all related forward statements wherever they appear in this Form 10-QSB/A.
The Company's actual results could differ materially from those discussed
here.

     Other than what has been disclosed herein and in the year end report for
year 2000, filed on April 16, 2001, the Company is not aware of any immediate
circumstances or trends which would have a negative impact upon future sales
or earnings.  There have been no material fluctuations in the standard
seasonal  variations of the Company business.  The accompanying financial
statements include all adjustments, which in the opinion of management are
necessary in order to make the financial statements not misleading.

The Company
-----------

     The Company presently has office space at no cost to the Company at 730
2nd Street Santa Rosa, CA 95402-3588.

Business of Issuer
------------------

     Our Company was originally formed as a Delaware corporation in 1958 under
the name Carrtone Laboratories, Inc.  We were engaged in the licensing of
patents held by our Company, collecting royalties on a patent and exploiting
and acquiring other patents and inventions including those related to heart
disease treatment, cancer treatment and asthma treatment technologies.
Finding the results unsuccessful, we allowed our patents to lapse and
discontinued business operations.  We eventually became inactive and lacked
the funds to maintain any operations.

     We were de-listed from the NASDAQ Bulletin Board stock exchange
("OTCBB")because we failed to file our periodic reports with the Securities
and Exchange Commission.  However, we have recently been reinstated and are
presently trading on the OTCBB under the symbol, "CYLI".

     We currently have little revenues and own very limited assets.  We have
no viable operations.  We will continue to seek a sale or business combination
transaction.


                                     -3-
<PAGE>
Because we have limited revenues we may be unable to satisfy any liabilities
incurred prior to the combination with a privately held company.  If
negotiations and transactions fail prior to a successful consummation, we may
not be able to continue to pursue new business opportunities with other
privately held companies.  If this occurs, it is foreseeable that our
Company's common stock may become worthless and our stockholders may receive,
if any, a nominal distribution, upon our Company's liquidation and
dissolution.

     We can not predict the resulting value of the merger or business
transaction for the owners of the privately held company selected for a
business combination.  The privately held company selected for the business
combination may incur significant expenses and costs associated with the
business combination including legal, accounting and administrative fees and
expenses.

Capital Resources and Liquidity
-------------------------------

     During the quarter ended September 30, 2001, the Company did not issue
any unregistered shares or register any shares of its common stock.

Results of Operations
---------------------

     For the three month ended September 30, 2001, the Company was not active
and there was no financial activity, as well.


                                    PART II


ITEM 1.  LEGAL PROCEEDINGS

     We are not aware of any material pending legal proceeding to which we are
a party or of which any of our property is the subject. We are not aware of
our Company's involvement in violations of Federal, State or local statutes or
ordinances with environmental protection.

ITEM 2. CHANGES IN SECURITIES

     During the quarter ended September 30, 2001, there were no changes in
securities.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

     During the quarter ended September 30, 2001, there were no defaults upon
senior securities.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

     During the quarter ended September 30, 2001, there were no matters
submitted to a vote of the Company's shareholders.

ITEM 5. OTHER

     None.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

     During the quarter ended September 30, 2001, there were no reports on
form 8-K.

     Exhibit No.         Description of Exhibit
     -----------         ----------------------

     EX-13               Unaudited financial statements for quarter ended
                         9/30/01

     EX-15               Representation Letter from Malone & Bailey, PLLC,
                         auditors re 9/30/01 unaudited financial statements



                                     -4-
<PAGE>

                                 SIGNATURES

     Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereunto duly authorized this 13th
day of November, 2001.


CENTURY LABORATORIES, INC.


 /s/ Robert Bryan
----------------------------
By: Robert Bryan, President




                                     -5-